Summary. In an attempt to study pancreatic A cell function at an early stage of pancreatic diabetes secondary to chronic pancreatitis, both intravenous glucose (0.5 g/kg) and insulin (0.5 U/kg) tolerance tests were performed on seven dogs with pancreatolithiasis and seven normal control dogs. Experimental pancreatolithiasis was produced 12 months after incomplete ligation of the greater pancreatic duct. Impaired glucose tolerance and reduced plasma insulin response to an intravenous glucose load were observed in the calcified group. Pancreatic release of glucagon to insulin-induced hypoglycaemia was diminished, but suppressive response of the hormone to glucose-induced hyperglycaemia was well preserved. These data suggest that the A cell response to hypoglycaemia may be impaired earlier than that to hyperglycaemia in pancreatic diabetes secondary to pancreatolithiasis.
Pancreatic lithiasis is a common late complication of long-standing chronic pancreatitis. Pancreatic diabetes occurs more often in patients with calcified than those with non-calcified pancreatitis [1, 2] . Little is known about pancreatic endocrine function at an early stage of diabetes associated with pancreatic lithiasis [3] .
In the present study an attempt was made to investigate the response of plasma pancreatic glucagon to glucose and insulin in dogs with pancreatolithiasis.
Materials and Methods

Animal Preparation
The 14 dogs were divided into two weight-matched groups; t 8+ 3 kg (range 14-24 kg) in the control group and 18_ r kg (range 14-25 kg) in other group. Details of the operative procedures for producing experimental pancreatolithiasis have been reported previously [4, 5] . The greater pancreatic duct was incompletely ligated with stainless steel wire. The lesser duct was ligated and then cut separately. The dogs were fed commercial dog food and the mean weight was not significantly changed during the 12months. Pancreatic calculi were identified by autopsy 12 months after the operation. The gland was indurated, nodular and atrophic. Acinar alterations including atrophy, disorganization and interlobular replacement of fibrous connective tissue were present in moderate degree. In the control dogs neither calculi nor histological abnormalities were found at autopsy.
Protocols of Pancreatic Endocrine Function Tests
Pancreatic endocrine function was studied by intravenous injection of glucose or insulin in the conscious state. In seven dogs with pancreatic calcification, the test was carried out 12 months after the surgical intervention.
Intravenous Glucose Tolerance Test:
A butterfly needle was inserted into an antecubital vein, and glucose (0.5 g/kg) infused for 2 min using a peristaltic pump (Gilson Minipuls Pump HP-1, Villiers-le-Bel, France). Blood was taken through the butterfly needle in the opposite antecubital vein before and after glucose infusion at regular intervals for 60 min.
Intravenous Insulin Tolerance Test:
Highly purified porcine insulin (Actrapid MC, Novo Research Institute, Denmark) in a dose of 0.5 U/kg in t ml of 0.9% NaCI solution was injected intravenously. Blood was drawn from the opposite antecubital vein before and after the rapid insulin injection at specified intervals for 120 rain.
Heparinized blood specimens were transferred immediately either into ice-chilled tubes for measurement of glucose and immunoreactive insulin (IRI) or into the tubes containing Na2 EDTA (1.2 mg/ml of blood) and aprotinin (1000 KIU/ml of blood, Trasylol, Bayer Pharmaceuticals, FRG) for measurement of immunoreactive glucagon (IRG). Plasma was stored at -20~ until determination of both IRI and IRG.
Assays and Statistical Analyses
Methods for the determination of plasma glucose, IRI and IRG (using Unger antibody 30K) have been described previously [5] . The disappearance rate of glucose (K) in plasma during the IV glucose toler- ance test, an index of glucose tolerance, was calculated from the exponential curve, using the formula of Lundbaek [6] . For comparison within a group, Student's t-test for paired data was used. The t-test for two groups was employed for comparison between groups. A difference in the probability value of less than 0.05 was taken as the level of significance. Results are presented as mean+ SEM.
Results
Plasma Glucose and IRI Responses to the IV Glucose Load
Plasma glucose concentration between control and calcified groups was significantly different only at 60 min ( Table 1) . The mean disappearance rates of glucose (K) were 3.30_+0.36 and 1.58_+0.17%/rain in the control and calcified groups, respectively. These values were significantly different (p< 0.01 ; Fig. 1 ).
Fasting IRI levels between the two groups were not statistically different. The IRI response after the IV glucose load in the calcified group was lower than in the control group. Statistical differences were observed at 2-15 min (Table 1) .
Plasma IRG Response to the IV Glucose Load
The IRG declined significantly from the basal value of 165 -+ 17 pg/ml to a nadir of 119 ___ 15 pg/ml in the control group and from 168_+ 50 to 115 + 35 pg/ml in the calcified group. The mean IRG decrements from the baseline were not significantly different between the two groups (Fig. 2) .
Plasma IRG Response to Insulin-Induced Hypoglycaemia
Intravenous injection of insulin caused a significant fall in plasma glucose concentration in both groups. Plasma glucose declined from the basal value of 4.3_+ 0.2 mmol/1 to a nadir of 2.1 _+ 0.2 retool/1 in the control group and from 4.6 _+ 0.1 to 1.7 _+ 0.2 mmol/1 in the calcified group.
After insulin, mean levels of IRG rose significantly from a basal value of 172 _+ 12 pg/ml to a maximum of 377 _+ 72 pg/ml in the control group (p< 0.05). Although the degree of hypoglycaemia was similar to that of the control group, the IRG response to insulin-induced hypoglycaemia was not significantly different in the calcified group (basal value: 194_+49 pg/ml, maximum: 258 _+ 37 pg/ml; Fig. 3 ).
Discussion
It has been reported that in overt diabetes secondary to chronic pancreatitis, suppression of pancreatic glucagon to an oral glucose load does not occur [1] , and that release of the hormone is reduced after intravenous arginine [7] or during insulin-induced hypoglycaemia [8] . However, little is known about A cell function at an ear- ly stage of diabetes secondary to chronic pancreatitis, especially that due to pancreatolithiasis. In the present study, two stimuli (glucose-induced hyperglycaemia and insulin-induced hypoglycaemia) were employed to assess pancreatic A cell function. The response of plasma IRG to intravenous administration of glucose or insulin is independent of gut hormones. The secretory capacity of the A cell in the pancreas was assessed by insulin-induced hypoglycaemia instead of an arginine load. Arginine stimulates secretion of gastric glucagon which is indistinguishable from pancreatic glucagon in normal dogs [9] , depancreatized dogs [10] [11] [12] , and isolated perfused dog stomach [13] ; in contrast gastric glucagon is not released during insulininduced hypoglycaemia in either normal [9] or depancreatized dogs [10] . Matsuyama et al. [10] reported that insulin-induced hypoglycaemia did not raise the plasma concentration of IRG in depancreatized dogs, but it was raised significantly in normal dogs. We confirmed their results in a preliminary experiment. Therefore, the IRG response to hypoglycaemia requires the presence of the pancreas and insulin-induced hypoglycaemia is a more specific stimulus to pancreatic glucagon secretion. In the present study, a significant rise of IRG to insulininduced hypoglycaemia was observed in the control dogs but not in the dogs with pancreatolithiasis.
Kirk et al. [14] reported plasma insulin and glucagon responses to a 25 g intravenous glucose infusion among non-diabetic first-degree relatives of diabetic and normal subjects. According to them the glucagon level was unchanged in first-degree relatives with diminished first-phase insulin release even in the presence of hyperglycaemia, while suppressed to a significant degree in the other relatives and control subjects. They concluded that their data provided evidence for an A cell abnormality of genetic diabetes. On the contrary, Aronoff et al. [15] failed to demonstrate an abnormal glucagon response to intravenous glucose infusion in prediabetic Pima Indians who had had two or more oral glucose tolerance tests during the past 10 years which were normal and whose parents both had diabetes. In the present study, hyperglycaemic suppression of IRG was observed in dogs with pancreatolithiasis as well as in control dogs, although both glucose tolerance and B cell function were impaired only in the former group. This is compatible with the results observed in man by Aronoff et al. [15] . The A cell response to an intravenous glucose load seems to be independent of B cell function in an early stage of pancreatic diabetes.
Ultrastructural changes of A and B cells appeared 3-6 months after duct ligation in dogs with pancreatolithiasis. Using an immunoperoxidase staining technique, the staining intensity was evaluated in the A cell for pancreatic glucagon and B cell for insulin in some of the dogs studied in this experiment. The intensity became weaker in the A as well as B cells in the pancreatolithiasis dogs when compared with the control dogs (unpublished data).
In conclusion, in a prediabetic state in experimental pancreatolithiasis pancreatic release of glucagon to insulin-induced hypoglycaemia was much impaired, but suppression of the hormone in response to hyperglycaemia occurred in much the same manner as in control dogs. Dysfunction of the A cell to hypoglycaemia seems to precede that to hyperglycaemia in diabetes secondary to pancreatolithiasis.
